Welcome to chemicalbook!
Chinese English Japanese Germany Korea
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

ChemicalBook CAS DataBase List ITI-722

ITI-722 synthesis

7synthesis methods
ITI-722 is a first-in-class dual 5HT2A receptor antagonist and dopamine receptor phosphoprotein modulator (DPPM).
Synthetic Routes
  • ROUTE 1
  • 202112071952604421.jpg

    Li, Peng; Zhang, Qiang; Robichaud, Albert J.; Lee, Taekyu; Tomesch, John; Yao, Wei; Beard, J. David; Snyder, Gretchen L.; Zhu, Hongwen; Peng, Youyi; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Mates, Sharon; Wennogle, Lawrence P. Discovery of a Tetracyclic Quinoxaline Derivative as a Potent and Orally Active Multifunctional Drug Candidate for the Treatment of Neuropsychiatric and Neurological Disorders. Journal of Medicinal Chemistry. Intra-Cellular Therapies, Inc. New York, USA 10032Volume 57. Issue 6. Pages 2670-2682. 2014.

  • ROUTE 2
  • 202112070581100014.jpg

    Tomesch, John Charles; Li, Peng; Yao, Wei; Zhang, Qiang; Beard, James David; Thompson, Andrew S.; Cheng, Hua. Process for preparation of heterocycle fused gamma-carbolines Assignee Intra-Cellular Therapies, Inc., USA. 2008. WO 2008112280.

  • ROUTE 3
  • 202112075182756583.jpg

    Robichaud, Albert J.; Lee, Taekyu; Deng, Wei; Mitchell, Ian S.; Haydar, Simon; Chen, Wenting; McClung, Christopher D.; Calvello, Emilie J. B.; Zawrotny, David M. Preparation of substituted heterocycle fused gamma-carbolines. Assignee Du Pont Pharmaceuticals Company, USA. 2000. WO 2000077010

202112071952604421.jpg

Li, Peng; Zhang, Qiang; Robichaud, Albert J.; Lee, Taekyu; Tomesch, John; Yao, Wei; Beard, J. David; Snyder, Gretchen L.; Zhu, Hongwen; Peng, Youyi; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Mates, Sharon; Wennogle, Lawrence P. Discovery of a Tetracyclic Quinoxaline Derivative as a Potent and Orally Active Multifunctional Drug Candidate for the Treatment of Neuropsychiatric and Neurological Disorders. Journal of Medicinal Chemistry. Intra-Cellular Therapies, Inc. New York, USA 10032Volume 57. Issue 6. Pages 2670-2682. 2014.

313368-85-3 Synthesis
(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline

313368-85-3
69 suppliers
inquiry

4'-fluoro-4-iodobutyrophenone

40862-32-6
5 suppliers
inquiry

ITI-722

313368-91-1
74 suppliers
inquiry

-

Yield:313368-91-1 84%

Reaction Conditions:

with caesium carbonate in acetonitrile at 20; for 24 h;Reagent/catalyst;Solvent;Temperature;

Steps:

9; 10 Method B

0.459 g (2.0 mmol) formula (II) compound is dissolved in 15 ml acetonitrile, then, to this, 1.303 g (4.0 mmol) caesium carbonate and 0.876 g (3.0 mmol) 4-iodo-4'-fluoro butyrophenone is added. The reaction mixture is stirred for 24 hours at room temperature. Then it is filtered and evaporated. The evaporation residue is dissolved in 20 ml dichlorom ethane and then extracted with 10 ml water, than with 10 ml saturated NaCl solution. The organic phase is dried on Na2S04, filtered and evaporated. The 1.06 g raw product obtained is cleaned on silica gel with flash chromatography using CfTCb-MeOH as eluent. 0.66 g (84%) formula (I) compound is obtained (light brown oil).

References:

WO2019/102240,2019,A1 Location in patent:Page/Page column 75; 76

313368-85-3 Synthesis
(6bR,10aS)-3-Methyl-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline

313368-85-3
69 suppliers
inquiry

3874-54-2 Synthesis
4-Chloro-4'-fluorobutyrophenone

3874-54-2
365 suppliers
$10.00/5G

ITI-722

313368-91-1
74 suppliers
inquiry